(S)-3-Amino-4-(3,4-difluorophenyl)butanoic acid hydrochloride is a chiral amino acid derivative featuring a 3,4-difluorophenyl group. It serves as a key chiral building block in pharmaceutical synthesis. The compound is a white to off-white crystalline powder. Its primary and well-documented application is as a critical intermediate in the synthesis of (S)-Dapoxetine, a short-acting selective serotonin reuptake inhibitor (SSRI) used for the treatment of premature ejaculation. The (S)-enantiomer is the pharmacologically active form. The synthesis process typically involves this compound as a precursor for constructing the core structure of the API. As a pharmaceutical intermediate, it is handled under controlled conditions. It is important to note that this compound is specifically designed and utilized for the production of a final active pharmaceutical ingredient (API) and is not a general-purpose laboratory reagent.